These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 12703985

  • 1. [Influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma].
    Li J, Luo SK, Hong WD, Zhou ZH, Zou WY.
    Ai Zheng; 2003 Apr; 22(4):346-9. PubMed ID: 12703985
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic effectiveness of thalidomide to multiple myeloma and its mechanism].
    Wang M, Liu Y, Li Y, Wu H.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):514-6. PubMed ID: 12482346
    [Abstract] [Full Text] [Related]

  • 3. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 4. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E, Terpos E, Papaioannou M, Hatjileontis C, Kaloutsi V, Galaktidou G, Gerotziafas G, Christakis J, Zervas K.
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [Abstract] [Full Text] [Related]

  • 5. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
    Du W, Hattori Y, Hashiguchi A, Kondoh K, Hozumi N, Ikeda Y, Sakamoto M, Hata J, Yamada T.
    Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Influence of thalidomide on interleukin-6 and its transmission in multiple myeloma patients].
    Li J, Luo S, Hong W, Zhou Z, Zou W.
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):254-6. PubMed ID: 12515619
    [Abstract] [Full Text] [Related]

  • 8. High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.
    Neben K, Moehler T, Egerer G, Kraemer A, Hillengass J, Benner A, Ho AD, Goldschmidt H.
    Clin Cancer Res; 2001 Sep; 7(9):2675-81. PubMed ID: 11555579
    [Abstract] [Full Text] [Related]

  • 9. Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma.
    Tosi P, Zamagni E, Cellini C, Ronconi S, Patriarca F, Ballerini F, Musto P, Di Raimondo F, Ledda A, Lauria F, Masini L, Gobbi M, Vacca A, Ria R, Cangini D, Tura S, Baccarani M, Cavo M.
    Haematologica; 2002 Apr; 87(4):408-14. PubMed ID: 11940485
    [Abstract] [Full Text] [Related]

  • 10. Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells.
    Li X, Liu X, Wang J, Wang Z, Jiang W, Reed E, Zhang Y, Liu Y, Li QQ.
    Anticancer Res; 2003 Apr; 23(3B):2481-7. PubMed ID: 12894531
    [Abstract] [Full Text] [Related]

  • 11. Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.
    Vacca A, Scavelli C, Montefusco V, Di Pietro G, Neri A, Mattioli M, Bicciato S, Nico B, Ribatti D, Dammacco F, Corradini P.
    J Clin Oncol; 2005 Aug 10; 23(23):5334-46. PubMed ID: 15939924
    [Abstract] [Full Text] [Related]

  • 12. [Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].
    Liu JR, Luo SK, Li J, Su C.
    Ai Zheng; 2007 Jun 10; 26(6):652-6. PubMed ID: 17562275
    [Abstract] [Full Text] [Related]

  • 13. Response to thalidomide in multiple myeloma: impact of angiogenic factors.
    Rosiñol L, Cibeira MT, Segarra M, Cid MC, Filella X, Aymerich M, Rozman M, Arenillas L, Esteve J, Bladé J, Montserrat E.
    Cytokine; 2004 May 21; 26(4):145-8. PubMed ID: 15149630
    [Abstract] [Full Text] [Related]

  • 14. Thalidomide for the treatment of multiple myeloma.
    Hattori Y, Iguchi T.
    Congenit Anom (Kyoto); 2004 Sep 21; 44(3):125-36. PubMed ID: 15327481
    [Abstract] [Full Text] [Related]

  • 15. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
    Gupta D, Treon SP, Shima Y, Hideshima T, Podar K, Tai YT, Lin B, Lentzsch S, Davies FE, Chauhan D, Schlossman RL, Richardson P, Ralph P, Wu L, Payvandi F, Muller G, Stirling DI, Anderson KC.
    Leukemia; 2001 Dec 21; 15(12):1950-61. PubMed ID: 11753617
    [Abstract] [Full Text] [Related]

  • 16. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT, Li XF, Breitkreutz I, Song W, Neri P, Catley L, Podar K, Hideshima T, Chauhan D, Raje N, Schlossman R, Richardson P, Munshi NC, Anderson KC.
    Cancer Res; 2006 Jul 01; 66(13):6675-82. PubMed ID: 16818641
    [Abstract] [Full Text] [Related]

  • 17. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
    Giuliani N, Colla S, Morandi F, Rizzoli V.
    Haematologica; 2004 Sep 01; 89(9):1118-23. PubMed ID: 15377473
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
    Nguyen AN, Stebbins EG, Henson M, O'Young G, Choi SJ, Quon D, Damm D, Reddy M, Ma JY, Haghnazari E, Kapoun AM, Medicherla S, Protter A, Schreiner GF, Kurihara N, Anderson J, Roodman GD, Navas TA, Higgins LS.
    Exp Cell Res; 2006 Jun 10; 312(10):1909-23. PubMed ID: 16600214
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.